Description
Bexitrol Inhaler 25/125 is a crucial metered-dose inhaler (MDI) prescribed for the regular maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). Each precise actuation delivers Salmeterol Xinafoate 25 mcg and Fluticasone Propionate 125 mcg. Salmeterol, a long-acting bronchodilator, provides sustained relief by relaxing airway muscles, ensuring easier breathing for up to 12 hours. Fluticasone, a potent inhaled corticosteroid, targets and reduces inflammation and swelling in the lungs, effectively preventing respiratory exacerbations. This dual-action approach offers comprehensive control, improving lung function and significantly reducing the frequency and severity of breathing difficulties. It is intended for daily, regular use as a controller medication, not for immediate relief of sudden breathlessness.
